ACC Congress 2025 Late-Breaking Science Collection

  • Published:  13 March 2025
  • Likes: 

    Heart Icon

    3

Up Next

ACC Congress 2025 Late-Breaking Science Collection

  • Published:  13 March 2025
  • Likes: 

    Heart Icon

    3

Average (ratings)
No ratings
Your rating
About the episode

Join renowned interventional cardiologists Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) for an exclusive preview of ACC.25's most significant late-breaking science. 

 

This episode of View from the Thoraxcenter delivers authoritative analysis of pivotal cardiovascular trials set to revolutionize clinical practice and research. Elevate your conference experience with this essential preview, where Prof Van Mieghem and Dr Daemen provide evidence-based insights that expertly contextualize each trial within today's cardiovascular landscape. Their seasoned perspective offers valuable clarity on how these groundbreaking findings will directly influence patient care protocols and shape the future of cardiology.

 

Trials covered include:
PROTECTED-TAVI
Evolut Low Risk: 5 Year Outcomes
TRILUMINATE
FLAVOUR II
FAME 3: 5 Year Outcomes
ECLIPSE
ALTSHOCK II
Comparison of DAPT Duration After Stenting in High and Low Bleeding Risk Populations
Clopidogrel Vs Aspirin Post-PCI in Patients with High Ischaemic Risk
DapaTAVI
FAIR-HF2
FRESH-UP

Overview

Keep up-to-date with our video collection on the American College of Cardiology's 74th annual congress, covering late-breaking science, featured science and clinical horizon sessions. Don't miss the preview and wrap-up of the congress in our View From the Thoraxcenter series, concise Expert Interviews with select faculty offering take-home messages for practice, and our Highlights summarising the most influential trials.

More from this programme

Faculty Biographies

Joost Daemen

Joost Daemen

Interventional Cardiologist

Dr Joost Daemen, MD, PhD is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam. 

Dr Daemen is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.

View full profile
Nicolas M Van Mieghem

Nicolas M Van Mieghem

Full Professor of Interventional Cardiology

Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors. 

 

Academic History

Prof. Nicolas M. Van Mieghem completed his medical training at the Catholic University of Leuven (Belgium), where he earned both his medical degree and his specialist degree in cardiology. During his time in Leuven, he developed a strong interest in cardiovascular medicine, particularly in the emerging field of minimally invasive cardiac interventions. After finishing his core medical and cardiology training, he pursued multiple advanced…

View full profile

Comments

You must be to comment. If you are not registered, you can register here.